Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imax Corp (NY: IMAX )

25.05 +0.34 (+1.38%)
Streaming Delayed Price Updated: 10:41 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Imax Corp

< Previous 1 2 3 4 5 6 7 8 Next >
Imax Stock Has a Lot to Prove This Week
The leader of premium theatrical experiences screens its latest financials on Tuesday afternoon. Grab the popcorn. 
Via The Motley Fool
Don't Bury Movie Theater Stocks... Yet
Movie-theater chains have had a rough start this year, but that should change as early as next month. 
Via The Motley Fool
MarketBeat ‘Stock of the Week’: Bowlero is on a roll
Bowlero's acquisition-driven growth strategy makes it a solid long-term investment strike while its squeeze potential makes it a spare worth picking up. 
Via MarketBeat
7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World
If the Federal Reserve loosens the monetary spigot, these companies could represent the growth stocks to buy now. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
AMC Stock Alert: Macquarie Issues Big Movie Theater Warning for 2024
AMC stock is trading lower after Macquarie lowered its price target to $8 from $9 and issued a box office warning for 2024. 
Via InvestorPlace
IMAX Q3 Earnings Smashes Estimates On Box Office Strength
IMAX Corp (NYSE: IMAX) reported third-quarter FY23  
Via Benzinga
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
Analyst Ratings for Imax
Via Benzinga
Analyst Ratings for Imax
Via Benzinga
Beyonce's "Renaissance Tour" Sparks Skin-Deep Controversy, Tina Knowles Hits Back At "Bozos" As Concert Film Debuts In AMC Theatres
Ahead of Beyonce’s "Renaissance Tour" opening, Tina Knowles, the superstar’s mother, took to Instagram to lash out at those who disparaged her daughter’s appearance at Saturday’s Los Angeles premier 
Via Benzinga
Will Beyonce Concert Film Give AMC Another #1 Hit? Could Shareholders Be Crazy In Love With Q4 Earnings?
A new concert film from Beyonce hits theaters this week and could provide a boost to AMC Entertainment Holdings stock. 
Via Benzinga
Profit from the Unknown: 3 Silent Market Movers to Watch Before They Boom
Are you looking to profit from the unknown? Here are three under the radar stocks to watch before they boom. 
Via InvestorPlace
No Feel-Good Hollywood Ending for AMC Stock
AMC stock fans received good news in terms of estimate-beating revenue and EPS. However, new share dilution poses major bad news. 
Via InvestorPlace
IMAX (IMAX) Q3 2023 Earnings Call Transcript
IMAX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Latest Analyst Ratings for Imax
Via Benzinga
My Take: 4 Strong Growth Stocks to Buy This Week
A lot of companies will be making news this week. Check out some of the names that could move higher. 
Via The Motley Fool
Cinemark and Imax Steal the Spotlight in Movie Theater Comeback
Cinemark Holdings and Imax are thriving as movie theaters bounce back, with Cinemark boasting the top price gains. Analysts expect Imax's EPS to grow by 662% 
Via MarketBeat
3 Stocks That Could Get a Big Taylor Swift Boost
The success of the businesses around Taylor Swift's Eras Tour stops has many investors thinking about stocks in need of a boost. 
Via InvestorPlace
IMAX's China Move Hits A Snag: Acquisition Proposal Fails To Pass Vote
IMAX Corporation (NYSE: IMAX) has confirmed that its proposal to acquire IMAX China's outstanding 96.3 million shares will not proceed  
Via Benzinga
IMAX's Remarkable Recovery - 3Q Box Office Earnings Highlight Strong Growth
Benchmark analyst Mike Hickey maintained Imax Corp (NYSE: IMAX) with a Buy and raised the p 
Via Benzinga
IMAX Corp. (NYSE: IMAX) Highlighted for Surprising Price Action
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
High-Stakes Picks: 7 Speculative Stocks for the Bold Investor
While speculative stock picks present extraordinary risks, these compelling ideas also enjoy the backing of Wall Street’s finest. 
Via InvestorPlace
Netflix To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Friday
Raymond James lowered the price target for Ulta Beauty, Inc. (NASDAQ: ULTA) from $600 to $550. Raymond James analyst Olivia Tong maintained a Strong Buy rating. Ulta Beauty shares gained 1.5% to... 
Via Benzinga
3 Growth Stocks That Could Make You Richer by 2030
These growth stocks can deliver wealth-building gains over the long term. 
Via The Motley Fool
The 7 Most Undervalued Entertainment Stocks to Buy Now: August 2023
Dive into the enticing world of undervalued entertainment stocks, showcasing remarkable post-pandemic growth opportunities 
Via InvestorPlace
3 Movie Theater Stocks That Even ‘Barbieheimer’ Can’t Save
Investors will be best-served by steering clear of these three movie theater stocks in the current environment 
Via InvestorPlace
IMAX Analyst Bullish On Stock As Box Office Revenue Shows Strong Recovery
Barrington Research analyst James Goss reiterated Imax Corp (NYSE: IMAX) shares with an Outperform rating and a  
Via Benzinga
Why IMAX Stock Trounced the Market Today
A powerful quarter gives a powerful lift to sentiment on the big-screen cinema specialist. 
Via The Motley Fool
IMAX Soars Following Upbeat Q2 Results: Analysts Bullish on Theatrical Rebound and Global Expansion
Imax Corp (NYSE: IMAX) stock is trading higher Thursday following upbeat Q 
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.